(Q37652055)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Srini V Kaveri

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Caroline Galeotti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Isabelle Kone-Paut

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

13 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

441-448

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

High levels of circulating interleukin-4 and interleukin-10 in Kawasaki disease

15 January 2020

cites work

1 reference

12 December 2020

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.

1 reference

12 December 2020

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids

1 reference

12 December 2020

Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.

1 reference

12 December 2020

Intravenous immunoglobulin therapy for autoimmune diseases

1 reference

12 December 2020

Association between a novel human coronavirus and Kawasaki disease

1 reference

12 December 2020

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

1 reference

12 December 2020

Pathogenic role of anti-endothelial cell antibodies in autoimmune rheumatic diseases

1 reference

12 December 2020

Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease

1 reference

12 December 2020

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

12 December 2020

Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon

1 reference

12 December 2020

The HLA class II region and susceptibility to Kawasaki disease

1 reference

12 December 2020

Safety of intravenous immunoglobulin (IVIG) therapy

1 reference

12 December 2020

Failure to Confirm the Presence of a Retrovirus in Cultured Lymphocytes from Patients with Kawasaki Syndrome

1 reference

12 December 2020

Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone

1 reference

12 December 2020

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

1 reference

12 December 2020

Variant Streptococcus sanguis as an etiological agent of Kawasaki disease

1 reference

12 December 2020

Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody

1 reference

12 December 2020

Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?

1 reference

12 December 2020

Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease

1 reference

12 December 2020

Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.

1 reference

12 December 2020

Primary Cytomegalovirus Infection, Atypical Kawasaki Disease, and Coronary Aneurysms in 2 Infants

1 reference

12 December 2020

Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease

1 reference

12 December 2020

Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages

1 reference

12 December 2020

1 reference

12 December 2020

CD25+CD4+ regulatory T cells in patients with Kawasaki disease.

1 reference

12 December 2020

Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues

1 reference

12 December 2020

Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children

1 reference

12 December 2020

The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies

1 reference

12 December 2020

Immunoglobulin allotypic markers in Kawasaki disease

1 reference

12 December 2020

Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease

1 reference

12 December 2020

Human regulatory T cells: role in autoimmune disease and therapeutic opportunities

1 reference

12 December 2020

Serum levels of neutrophil activation cytokines in Kawasaki disease

1 reference

12 December 2020

Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease

1 reference

12 December 2020

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

1 reference

12 December 2020

Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases

1 reference

12 December 2020

IVIG reduced vascular oxidative stress in patients with Kawasaki disease

1 reference

12 December 2020

New developments in the search for the etiologic agent of Kawasaki disease

1 reference

12 December 2020

Regulatory T cells and immune tolerance

1 reference

12 December 2020

Genetic analysis of Kawasaki syndrome

1 reference

12 December 2020

Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph-node syndrome

1 reference

12 December 2020

Incomplete Kawasaki disease with coronary artery involvement

1 reference

12 December 2020

Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease.

1 reference

12 December 2020

Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease

1 reference

12 December 2020

Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)

1 reference

12 December 2020

Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome).

1 reference

12 December 2020

Potential target of infliximab in autoimmune and inflammatory diseases

1 reference

12 December 2020

Kawasaki syndrome: association with the application of rug shampoo

1 reference

12 December 2020

Urine mercury levels in Kawasaki disease

1 reference

12 December 2020

Characterization of T cell repertoire changes in acute Kawasaki disease

1 reference

12 December 2020

A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease

1 reference

12 December 2020

Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease

1 reference

12 December 2020

IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease

1 reference

12 December 2020

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease

1 reference

12 December 2020

Longstanding Obliterative Panarteritis in Kawasaki Disease: Lack of Cyclosporin A Effect

1 reference

12 December 2020

Autoimmunity: CTLA-4: a key protein in autoimmunity

1 reference

12 December 2020

1 reference

12 December 2020

The role of the endothelium in systemic vasculitis

1 reference

12 December 2020

Biologically active anti-nerve growth factor antibodies in commercial intravenous gammaglobulin

1 reference

12 December 2020

What is the contents of the magic draft IVIg?

1 reference

12 December 2020

Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy

1 reference

12 December 2020

Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease

1 reference

12 December 2020

Intravenous gamma-globulin treatment in Kawasaki disease

1 reference

12 December 2020

Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MLNS) in an infant.

1 reference

12 December 2020

Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels

1 reference

12 December 2020

An update on Kawasaki disease

1 reference

12 December 2020

Anti-inflammatory actions of intravenous immunoglobulin

1 reference

12 December 2020

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

1 reference

12 December 2020

Immunoglobulin failure and retreatment in Kawasaki disease

1 reference

12 December 2020

Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment

1 reference

12 December 2020

Evidence for the use of intravenous immunoglobulins--a review of the literature

1 reference

12 December 2020

Initial intravenous gammaglobulin treatment failure in Kawasaki disease

1 reference

12 December 2020

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome

1 reference

12 December 2020

Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease

1 reference

12 December 2020

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

12 December 2020

Modulation of human dendritic cell maturation and function by natural IgG antibodies

1 reference

12 December 2020

Increased nitric oxide production by neutrophils in early stage of Kawasaki disease

1 reference

12 December 2020

Does Kawasaki disease have a retroviral aetiology?

1 reference

12 December 2020

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

1 reference

12 December 2020

Plasma exchange for refractory Kawasaki disease

1 reference

12 December 2020

Clonal expansion of CD8+ T cells in Kawasaki disease

1 reference

12 December 2020

Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006

1 reference

12 December 2020

Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

Salicylate for the treatment of Kawasaki disease in children

1 reference

12 December 2020

Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86

1 reference

12 December 2020

Leptospiral antibody and MLNS

1 reference

12 December 2020

Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome

1 reference

12 December 2020

Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

1 reference

12 December 2020

Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg).

1 reference

12 December 2020

The antiinflammatory IgG.

1 reference

12 December 2020

Gene Expression Profiling of the Effect of High-Dose Intravenous Ig in Patients with Kawasaki Disease

1 reference

12 December 2020

Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.

1 reference

12 December 2020

Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Role of natural antibodies in immune homeostasis: IVIg perspective.

1 reference

12 December 2020

Incomplete (atypical) Kawasaki disease

1 reference

12 December 2020

The infectious etiology of vasculitis

1 reference

12 December 2020

Infliximab treatment for refractory Kawasaki syndrome

1 reference

12 December 2020

Modulation of the cellular immune system by intravenous immunoglobulin

1 reference

12 December 2020

10.1016/J.AUTREV.2009.12.004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20004744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference